The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Authors
Keywords
Acute Myeloid Leukemia, Valproic Acid, Acute Myeloid Leukemia Patient, Decitabine, Clofarabine
Journal
Clinical Epigenetics
Volume 5, Issue 1, Pages 13
Publisher
Springer Nature
Online
2013-08-01
DOI
10.1186/1868-7083-5-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decitabine in Older Adults With Acute Myeloid Leukemia: Why Was the Dream Broken?
- (2013) Hagop Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: Serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment
- (2012) Hanne Fredly et al. AMERICAN JOURNAL OF HEMATOLOGY
- Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients
- (2012) Stefan Faderl et al. CANCER
- Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
- (2012) Stefan Faderl et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management
- (2011) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- Acute myeloid leukaemia in the elderly: a review
- (2011) Daniel A. Pollyea et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment
- (2011) Roland B. Walter et al. JOURNAL OF CLINICAL ONCOLOGY
- Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia hasin vitrobut limited clinical activity
- (2011) Steven Lane et al. LEUKEMIA & LYMPHOMA
- Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C
- (2011) M.T. Corsetti et al. LEUKEMIA RESEARCH
- Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
- (2010) H. Kantarjian et al. BLOOD
- Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells
- (2010) Elisabeth Ersvaer et al. BMC IMMUNOLOGY
- Vorinostat in acute myeloid leukemia and myelodysplastic syndromes
- (2010) Thomas Prebet et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Elevated frequencies of CD4+CD25+CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia
- (2010) Zhang Shenghui et al. INTERNATIONAL JOURNAL OF CANCER
- Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia
- (2010) A Quintás-Cardama et al. LEUKEMIA
- Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
- (2010) W. Blum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
- (2009) L. Ades et al. BLOOD
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia
- (2009) C. Wu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
- (2009) M. J. Szczepanski et al. CLINICAL CANCER RESEARCH
- A phase 2 study of vorinostat in acute myeloid leukemia
- (2009) E. W. Schaefer et al. HAEMATOLOGICA
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
- (2009) Amanda F. Cashen et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2008) S. Faderl et al. BLOOD
- Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia
- (2008) Shabbir M.H. Alibhai et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- In vivobiological effects of ATRA in the treatment of AML
- (2008) Anita Ryningen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started